MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway
- PMID: 31378898
- DOI: 10.26355/eurrev_201908_18543
MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway
Abstract
Objective: Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy with physiological microRNA (miR) pathomorphological changes. MiR-548c-3p participates in multiple processes of tumor development and progression. However, the role of miR-548c-3p in PTC and the underlying mechanisms remain undefined. Therefore, this study aimed to detect the expression of miR-548c-3p in PTC and to explore its exact function.
Materials and methods: MiR-548c-3p expression was analyzed in PTC tissue and cell lines by Real-Time fluorescence quantitative Polymerase Chain Reaction. Colony formation and cell viability assay were used to measure cell proliferation. Wound healing assay and transwell invasion assay were conducted to examine cell migration and invasion. The protein expression of the signaling pathways was determined by Western blot analysis.
Results: Our results indicated that miR-548c-3p was downregulated in PTC tissues and cell lines. Moreover, miR-548c-3p mimics suppressed PTC cell viability, colony formation, cell migration, and invasion capacity. Low expression of miR-548c-3p significantly enhanced N-cadherin and vimentin expression. A negative correlation was determined between miR-548c-3p and hypoxia-inducible factor (HIF) 1α or vascular endothelial growth factor (VEGF) levels, indicating that miR-548c-3p inhibited tumor progression by suppressing the HIF1α-mediated VEGF signaling pathway.
Conclusions: MiR-548c-3p could suppress PTC progression by inhibiting the HIF1α-mediated VEGF signaling pathway.
Similar articles
-
MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3421-3430. doi: 10.26355/eurrev_201904_17706. Eur Rev Med Pharmacol Sci. 2019. PMID: 31081096
-
Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa344. doi: 10.1210/clinem/dgaa344. J Clin Endocrinol Metab. 2020. PMID: 32492708
-
Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p.Cancer Med. 2020 Mar;9(5):1830-1841. doi: 10.1002/cam4.2839. Epub 2020 Jan 13. Cancer Med. 2020. PMID: 31943867 Free PMC article.
-
Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression.Arch Endocrinol Metab. 2019 Sep 2;63(5):536-544. doi: 10.20945/2359-3997000000172. eCollection 2019. Arch Endocrinol Metab. 2019. PMID: 31482959 Free PMC article. Review.
-
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020.Cancers (Basel). 2020 Oct 25;12(11):3118. doi: 10.3390/cancers12113118. Cancers (Basel). 2020. PMID: 33113852 Free PMC article. Review.
Cited by
-
Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.Front Endocrinol (Lausanne). 2023 Nov 27;14:1261860. doi: 10.3389/fendo.2023.1261860. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38089632 Free PMC article. Review.
-
MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil.Heliyon. 2023 Nov 5;9(11):e21775. doi: 10.1016/j.heliyon.2023.e21775. eCollection 2023 Nov. Heliyon. 2023. PMID: 38045156 Free PMC article.
-
Circ_0002395 promotes aerobic glycolysis and proliferation in pancreatic adenocarcinoma cells via miR-548c-3p/PDK1 axis.J Bioenerg Biomembr. 2024 Feb;56(1):55-71. doi: 10.1007/s10863-023-09995-2. Epub 2023 Dec 2. J Bioenerg Biomembr. 2024. PMID: 38041751
-
Circulating miR-548c-3p possesses good diagnostic potential for metabolic syndrome.Genes Dis. 2022 Jul 14;10(3):683-686. doi: 10.1016/j.gendis.2022.06.008. eCollection 2023 May. Genes Dis. 2022. PMID: 37396525 Free PMC article. No abstract available.
-
NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.Eur J Med Res. 2022 Nov 8;27(1):235. doi: 10.1186/s40001-022-00853-2. Eur J Med Res. 2022. PMID: 36348408 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
